There are currently 28 active clinical trials seeking participants for Endometriosis research studies. The states with the highest number of trials for Autism participants are Florida, Texas, California and Ohio.
A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules
NCT04464187
Recruiting
Orilissa is a drug approved for the management of moderate to severe pain associated with endometriosis. Oriahnn is approved for heavy menstrual bleeding due to uterine fibroids. Elagolix-containing products should not be taken by women who are pregnant or suspected to be pregnant but pregnancies are expected as the medicine does not completely stop ovulation and women may inadvertently continue taking Elagolix-containing products until their pregnancy is confirmed. This study will assess pregn... Read More
Gender:
Female
Ages:
All
Trial Updated:
05/24/2023
Locations: Iqvia /Id# 240918, Durham, North Carolina
Conditions: Endometriosis, Uterine Fibrioids
Register for Updates
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
NCT05698212
Recruiting
This study is testing a way to diagnose endometriosis using a uterine tissue biopsy (similar to a pap smear) as opposed to undergoing laparoscopy surgery. The tissue is sent to lab for cellular analysis with a proprietary AI (artificial intelligence) technology.
Gender:
Female
Ages:
Between 18 years and 50 years
Trial Updated:
01/24/2023
Locations: Valley OB-GYN Clinic, PC, Saginaw, Michigan +2 locations
Conditions: Endometriosis, Diagnosis
Register for Updates
Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
NCT05096065
Recruiting
The pharmacodynamic endpoint of percentage of subjects with suppressed estradiol level (less than 20 pg/mL) on cycle day 29 is the primary endpoint of the study.
Gender:
Female
Ages:
Between 18 years and 49 years
Trial Updated:
03/21/2022
Locations: Physician Care Clinical Research, LLC, Sarasota, Florida +3 locations
Conditions: Endometriosis
Register for Updates
The EMPOWER Study: Endometriosis Diagnosis Using microRNA
NCT04598698
Recruiting
Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visi... Read More
Gender:
Female
Ages:
Between 18 years and 49 years
Trial Updated:
01/11/2022
Locations: Stanford University Hospital, Palo Alto, California +22 locations
Conditions: Endometriosis
Register for Updates